As of 2026-10-03, the Relative Valuation of Biomarin Pharmaceutical Inc (BMRN) is 36.98 USD. This relative valuation is based on P/E multiples. With the latest stock price at 57.18 USD, the upside of Biomarin Pharmaceutical Inc based on Relative Valuation is -35.3%.
The range of the Relative Valuation is 8.72 - 65.41 USD.
| Range | Selected | |
| Trailing P/E multiples | 23.1x - 43.5x | 27.8x |
| Forward P/E multiples | 22.8x - 24.9x | 24.2x |
| Fair Price | 8.72 - 65.41 | 36.98 |
| Upside | -84.7% - 14.4% | -35.3% |
| Date | P/E |
| 2026-10-02 | 151.45 |
| 2026-10-01 | 154.79 |
| 2026-09-30 | 158.92 |
| 2026-09-29 | 158.58 |
| 2026-09-28 | 157.49 |
| 2026-09-25 | 159.61 |
| 2026-09-24 | 162.50 |
| 2026-09-23 | 164.77 |
| 2026-09-22 | 167.85 |
| 2026-09-21 | 169.67 |
| 2026-09-18 | 169.36 |
| 2026-09-17 | 172.38 |
| 2026-09-16 | 171.45 |
| 2026-09-15 | 170.71 |
| 2026-09-14 | 175.90 |
| 2026-09-11 | 173.97 |
| 2026-09-10 | 173.52 |
| 2026-09-09 | 170.60 |
| 2026-09-08 | 171.18 |
| 2026-09-04 | 176.22 |
| 2026-09-03 | 175.95 |
| 2026-09-02 | 177.38 |
| 2026-09-01 | 171.74 |
| 2026-08-31 | 172.77 |
| 2026-08-28 | 171.28 |
| 2026-08-27 | 172.93 |
| 2026-08-26 | 173.78 |
| 2026-08-25 | 175.13 |
| 2026-08-24 | 172.35 |
| 2026-08-21 | 176.67 |
| 2026-08-20 | 179.26 |
| 2026-08-19 | 183.63 |
| 2026-08-18 | 177.44 |
| 2026-08-17 | 176.51 |
| 2026-08-14 | 178.42 |
| 2026-08-13 | 181.51 |
| 2026-08-12 | 186.04 |
| 2026-08-11 | 184.22 |
| 2026-08-10 | 182.44 |
| 2026-08-07 | 169.01 |
| 2026-08-06 | 162.79 |
| 2026-08-05 | 158.68 |
| 2026-08-04 | 160.83 |
| 2026-08-03 | 158.91 |
| 2026-07-31 | 158.97 |
| 2026-07-30 | 160.46 |
| 2026-07-29 | 162.55 |
| 2026-07-28 | 164.40 |
| 2026-07-27 | 159.64 |
| 2026-07-24 | 157.15 |